University Of British Columbia
Tafasitamab regimen confers ‘quite remarkable’ PFS benefit in advanced follicular lymphoma
SAN DIEGO — The addition of tafasitamab-cxix to lenalidomide and rituximab reduced risk for progression, relapse or death by more than 50% for patients with relapsed or refractory follicular lymphoma, according to study results.
COPD exacerbations heighten risk for severe cardiovascular events, death across countries
Across four countries, the risk for a severe cardiovascular event or death was high 1 to 6 months after a moderate COPD exacerbation, according to a poster presented at the European Respiratory Society International Congress.
Most major CV guidelines mention but do not incorporate shared decision-making
Approximately half of all guidelines published by three major CV societies during the past decade mention “shared decision-making,” yet just 6% of recommendations incorporated shared decision-making in any form, researchers reported.
AI model uses physician notes to predict survival after cancer diagnosis
Researchers from University of British Columbia have developed an artificial intelligence model that can accurately predict survival after a cancer diagnosis using physician notes from an initial oncology consult.
Early detection, treatment of cardiac implantable device infections may reduce death risk
Cardiac implantable electronic device infections are most common within the first months after a procedure, decreasing significantly after the initial 3 months, data show.
SCAI, HRS release joint consensus statement on transcatheter LAA closure for AF
The Society for Cardiovascular Angiography and Interventions and the Heart Rhythm Society released an updated expert consensus statement on transcatheter left atrial appendage closure for atrial fibrillation.
‘Potential cardiovascular risk’ for some on keto-style diet
NEW ORLEANS — Certain traditional risk factors including severe high cholesterol, diabetes, hypertension and smoking may increase CV risk among those following a low-carbohydrate, high-fat “keto-style diet,” a speaker reported here.
FDA grants 510(k) clearance for ureteroscope system LithoVue
The FDA granted 510(k) clearance to Boston Scientific Corporation for its LithoVue Elite Single-Use Digital Flexible Ureteroscope System, according to a press release.
Convolutional neural networks may be used to perform lower limb alignment, axes analysis
Convolutional neural networks may be used to perform lower limb alignment and axes analysis with similar outcomes to orthopedic surgery fellows, according to results.
Inhaled dual bronchodilators did not reduce symptoms in adults with smoking history
Inhaled dual bronchodilator therapy did not decrease respiratory symptoms among individuals who were current or former smokers and had respiratory symptoms but preserved lung function without COPD, according to results of the RETHINC study.